ARTICLE | Clinical News
Amunix, Versartis preclinical data
October 5, 2009 7:00 AM UTC
In a mouse model of obesity, monthly VRS-859 resulted in weight loss comparable to twice-daily exenatide. Pharmacokinetic studies in mice, rats, dogs and monkeys support 100 mg VRS-859 as a monthly do...